|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/755 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| C07K 17/08 | (2006.01) |
| (11) | Number of the document | 2363414 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11153300.6 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2011-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2022-05-18 |
| (46) | Date of publication of the claims translation | 2022-10-25 |
| (30) | Number | Date | Country code |
| 627277 P | 2004-11-12 | US |
| (72) |
Pan, Clark Q. , US
Murphy, John E. , US
Mei, Baisong , US
Strauss, Jonathan S. , US
Tjandra, Hendri , US
Chen, Jianmin , US
Barnett, Thomas , US
Tang, Liang , US
Wamg, Deqian , US
|
| (73) |
Bayer HealthCare LLC ,
100 Bayer Boulevard
P.O. Box 915, Whippany, NJ 07981-0915,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | FVIII modifikacija, nukreipta į tam tikrą vietą |
| Site-directed modification of FVIII |
| Payment date | Validity (years) | Amount | |
| 2023-10-30 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-11-14 |